CICI
MRNA icon

Capital Investment Counsel Inc’s Moderna MRNA Stock Holding History

Capital Investment Counsel Inc’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,425
Closed -$256K – 172
2022
Q4 		$256K Buy
+1,425
New +$233K 0.06% 140

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Investment Counsel Inc's MRNA Position: Q1 2023 in Review

Capital Investment Counsel Inc sold out of Moderna (MRNA) in Q1 2023, closing a stake of 1,425 shares — an estimated $256K sold.

Capital Investment Counsel Inc first reported a position in MRNA in Q4 2022 and held it in 1 quarter. The position peaked at $256K in Q4 2022. 1,017 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Capital Investment Counsel Inc reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Capital Investment Counsel Inc sold 1,425 Moderna shares in Q1 2023, an estimated $256K.
  • Capital Investment Counsel Inc first reported a position in Moderna in Q4 2022 and held it in 1 quarter.
  • Capital Investment Counsel Inc's Moderna position peaked at $256K in Q4 2022.
  • 1,017 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Capital Investment Counsel Inc's 13F filing for Q1 2023, filed 27 Apr 2023.